Cancer biotech Calithera Biosciences pulled off an $80 million Wall Street debut, pricing well below its range as more and more drug developers line up in hopes of making it out of a tightening IPO window.

…read more

Source: Calithera ekes out an $80M IPO as Dermira, Forward hope for a turnaround


0 No comments